88 related articles for article (PubMed ID: 22679108)
1. GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells.
Kubic JD; Mascarenhas JB; Iizuka T; Wolfgeher D; Lang D
Mol Cancer Res; 2012 Aug; 10(8):1065-76. PubMed ID: 22679108
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer.
Pal K; Cao Y; Gaisina IN; Bhattacharya S; Dutta SK; Wang E; Gunosewoyo H; Kozikowski AP; Billadeau DD; Mukhopadhyay D
Mol Cancer Ther; 2014 Feb; 13(2):285-96. PubMed ID: 24327518
[TBL] [Abstract][Full Text] [Related]
3. TBX2 expression is regulated by PAX3 in the melanocyte lineage.
Liu F; Cao J; Lv J; Dong L; Pier E; Xu GX; Wang RA; Xu Z; Goding C; Cui R
Pigment Cell Melanoma Res; 2013 Jan; 26(1):67-77. PubMed ID: 23020925
[TBL] [Abstract][Full Text] [Related]
4. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
[TBL] [Abstract][Full Text] [Related]
5. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
[TBL] [Abstract][Full Text] [Related]
6. Phytochemical Analysis, In Vitro Biological Activities, and Computer-Aided Analysis of
Sharma S; Kumar V; Yaseen M; S Abouzied A; Arshad A; Bhat MA; Naglah AM; Patel CN; Sivakumar PK; Sourirajan A; Shahzad A; Dev K
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446769
[No Abstract] [Full Text] [Related]
7. Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer.
Elmadbouh OHM; Pandol SJ; Edderkaoui M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430630
[TBL] [Abstract][Full Text] [Related]
8. NUMB as a Therapeutic Target for Melanoma.
Hristova DM; Fukumoto T; Takemori C; Gao L; Hua X; Wang JX; Li L; Beqiri M; Watters A; Vultur A; Gimie Y; Rebecca V; Samarkina A; Jimbo H; Nishigori C; Zhang J; Cheng C; Wei Z; Somasundaram R; Fukunaga-Kalabis M; Herlyn M
J Invest Dermatol; 2022 Jul; 142(7):1882-1892.e5. PubMed ID: 34883044
[TBL] [Abstract][Full Text] [Related]
9. Proteomics and Phosphoproteomics Profiling of Drug-Addicted BRAFi-Resistant Melanoma Cells.
Li B; Kong X; Post H; Raaijmakers L; Peeper DS; Altelaar M
J Proteome Res; 2021 Sep; 20(9):4381-4392. PubMed ID: 34343000
[TBL] [Abstract][Full Text] [Related]
10. Targeting Pan-ETS Factors Inhibits Melanoma Progression.
Huang L; Zhai Y; La J; Lui JW; Moore SPG; Little EC; Xiao S; Haresi AJ; Brem C; Bhawan J; Lang D
Cancer Res; 2021 Apr; 81(8):2071-2085. PubMed ID: 33526511
[TBL] [Abstract][Full Text] [Related]
11. Glycogen Synthase Kinase 3β in Cancer Biology and Treatment.
Domoto T; Uehara M; Bolidong D; Minamoto T
Cells; 2020 Jun; 9(6):. PubMed ID: 32503133
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effects of Deuterium-Depleted Water (DDW) Against H
Wu Y; Qin D; Yang H; Wang W; Xiao J; Zhou L; Fu H
Neurochem Res; 2020 May; 45(5):1034-1044. PubMed ID: 32016793
[TBL] [Abstract][Full Text] [Related]
13. The expression and function of PAX3 in development and disease.
Boudjadi S; Chatterjee B; Sun W; Vemu P; Barr FG
Gene; 2018 Aug; 666():145-157. PubMed ID: 29730428
[TBL] [Abstract][Full Text] [Related]
14. Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.
Mancinelli R; Carpino G; Petrungaro S; Mammola CL; Tomaipitinca L; Filippini A; Facchiano A; Ziparo E; Giampietri C
Oxid Med Cell Longev; 2017; 2017():4629495. PubMed ID: 29379583
[TBL] [Abstract][Full Text] [Related]
15. Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer.
Walz A; Ugolkov A; Chandra S; Kozikowski A; Carneiro BA; O'Halloran TV; Giles FJ; Billadeau DD; Mazar AP
Clin Cancer Res; 2017 Apr; 23(8):1891-1897. PubMed ID: 28053024
[TBL] [Abstract][Full Text] [Related]
16. BRAF activates PAX3 to control muscle precursor cell migration during forelimb muscle development.
Shin J; Watanabe S; Hoelper S; Krüger M; Kostin S; Pöling J; Kubin T; Braun T
Elife; 2016 Dec; 5():. PubMed ID: 27906130
[TBL] [Abstract][Full Text] [Related]
17. Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22.
Zhou A; Lin K; Zhang S; Chen Y; Zhang N; Xue J; Wang Z; Aldape KD; Xie K; Woodgett JR; Huang S
Nat Cell Biol; 2016 Sep; 18(9):954-966. PubMed ID: 27501329
[TBL] [Abstract][Full Text] [Related]
18. A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.
Agaësse G; Barbollat-Boutrand L; Sulpice E; Bhajun R; El Kharbili M; Berthier-Vergnes O; Degoul F; de la Fouchardière A; Berger E; Voeltzel T; Lamartine J; Gidrol X; Masse I
Oncogene; 2017 Jan; 36(4):446-457. PubMed ID: 27375018
[TBL] [Abstract][Full Text] [Related]
19. PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.
Kubic JD; Lui JW; Little EC; Ludvik AE; Konda S; Salgia R; Aplin AE; Lang D
J Biol Chem; 2015 Sep; 290(36):21901-14. PubMed ID: 26205821
[TBL] [Abstract][Full Text] [Related]
20. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.
Wellbrock C; Arozarena I
Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
